Skip to main content
. 2020 Aug 15;202(4):549–557. doi: 10.1164/rccm.201910-2058OC

Figure 2.

Figure 2.

Consolidated Standards of Reporting Trials diagram of the targeted retreatment of exacerbations in chronic obstructive pulmonary disease (COPD): a double-blind, randomized, placebo-controlled, multicenter, phase III trial. IMP = investigational medicinal product.